SCHEMBL9515256

SCHEMBL9515256

Cc1c(O)c(=O)ccn1CCCNCCn1ccc(=O)c(O)c1C

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.53
▸ HRH3 Q9Y5N1 1/20 0.53
▸ KDM4E B2RXH2 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ KDM6A O15550 1/20 0.49
▸ KDM4A O75164 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KDM5C P41229 1/20 0.49
▸ KDM2B Q8NHM5 1/20 0.49
▸ DOHH Q9BU89 1/20 0.49
▸ KDM2A Q9Y2K7 1/20 0.49
▸ MAOB P27338 11/20 0.46
▸ COMT P21964 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4951999 0.89 APP (0.49) APPHRH3KDM4ETP53CYP2D6
SCHEMBL12288571 0.88 KDM4E (0.50) APPHRH3KDM4ETP53CYP2D6
Hydrochloric Acid SCHEMBL4952642 0.88 APP (0.48) APPHRH3KDM4ETP53CYP2D6
SCHEMBL10359200 0.84 APP (0.61) APPHRH3KDM4ETP53CYP2D6
SCHEMBL9513592 0.84 APP (0.61) APPHRH3KDM4ETP53CYP2D6
SCHEMBL15660704 0.84 KDM4E (0.60) APPHRH3KDM4ETP53CYP2D6
SCHEMBL15128362 0.83 KDM4E (0.54) APPHRH3KDM4ETP53CYP2D6
SCHEMBL5136933 0.81 APP (0.58) APPHRH3KDM4ETP53CYP2D6
SCHEMBL7152347 0.81 APP (0.58) APPHRH3KDM4ETP53CYP2D6
SCHEMBL15658806 0.80 CHRM2 (0.52) APPHRH3KDM4ETP53CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0357150-B1 Pharmaceutical compositions BRITISH TECH GROUP (GB) 1993-12-08 — — EP disclosed
US-5104865-A IRON COMPLEXES OF HYDROXYPYRIDONES USEFUL FOR TREATING IRON OVERLOAD NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1992-04-14 — — US disclosed
EP-0138421-B1 HYDROXYPYRIDONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-12-05 — — EP disclosed
US-4912118-A Therapy for toxic concentration of metal NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-03-27 — — US disclosed
EP-0357150-A1 Pharmaceutical compositions BTG INTERNATIONAL LIMITED (GB) 1990-03-07 — — EP disclosed
EP-0138421-A2 Hydroxypyridone derivatives and pharmaceutical compositions containing them NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-04-24 — — EP disclosed
Send feedback